Underneath Numerous Moving Parts, Fresenius Medical Care Retains Stable Performance
Fresenius Medical Care’s results continue to mostly track our expectations after stripping out negative currency effects, accounting changes under IFRS 15, the ongoing reimbursement transition for IV calcimimetic Parsabiv, the divestment of Sound, and a tax benefit. After adjusting for a number of these factors, Fresenius attained 5% revenue and 6% net income growth for the quarter. Additionally, management remains confident that the NxStage acquisition will close in the back half of this year. ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.